Status: Not yet recruiting
A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillation
The goal of the ReDEFINE-AF Clinical Study is to evaluate the safety and effectiveness of the FARAFLEX™ Mapping and Pulsed Field Ablation System with electrographic flow mapping in subjects undergoing repeat ablation for atrial fibrillation (AF).
Participants needed: 650
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Scientific CorporationUpdated: Sep 28, 2026
Eligibility criteria
At least 18 years old, or older if required by local law. [+4]
Left atrial anteroposterior (LA) diameter ≥ 6.5 cm, or if LA diameter is not ava... [+51]